TG THERAPEUTICS, INC.: cashflow_financing

Value{"amount": -89729000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2025-01-01 – 2025-12-31
Statuscurrent
EntityTG THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001437749-26-006133
Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001001316/cashflow-financing/2025-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b46a757f-25fb-4593-a393-eb23eacd2417

History